OCUL
Ocular Therapeutix Inc
7.30$
+1.2%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +7.6% | -4.0% | +3.9% | +0.3% | -0.8% | +3.2% | +4.6% | +4.2% | +16.7% | +2.9% | +44.3% | – | |
| – | -4.1% | +84.3% | +41.6% | -41.2% | +8.4% | +45.3% | -7.4% | +20.8% | -2.8% | +37.2% | -6.0% | – | |
| – | -205.3% | – | – | -138.7% | – | +544.6% | -90.0% | +575.4% | -156.4% | – | -615.6% | – | |
| – | +77.2% | -44.4% | +191.0% | -88.0% | +127.0% | +856.9% | -35.6% | +381.4% | -52.6% | +64.2% | -27.8% | – | |
| – | +77.2% | -44.4% | +191.0% | -88.0% | +127.0% | +856.9% | -42.3% | +437.5% | -52.6% | +64.2% | -27.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +89.4% | +197.0% | -99.3% | +90.3% | +8.0% | -7.3% | +2,238.2% | -89.4% | +4,239.3% | -99.9% | +777.9% | – | |
| – | +94.0% | +236.7% | -108.1% | – | – | – | – | -211.8% | – | -117.9% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.